New DEA-Exempted CBDA Certified Reference Material Tests Medical Cannabis Potency with Greater Accuracy

Chromatography

New DEA-Exempted CBDA Certified Reference Material Tests Medical Cannabis Potency with Greater Accuracy

24 Nov, 2016

Published over 9 years ago. See the latest and most current information on Chromatography.

Restek has expanded its selection of cannabinoid-related reference standards by adding cannabidiolic acid (CBDA). This 1,000 ppm standard is DEA-exempted, so there’s no need to purchase costly neat materials or to make your own standards, and it is prepared in acetonitrile, which helps maintain stability by preventing methylation of the carboxylic acid group on the molecule. Paired with Restek’s THC standards, it is perfect for the analysis of both neutrals and acids in cannabis products by LC and is a must for accurate quantification in medical cannabis potency testing and strain ID. Restek’s CBDA standard is also a certified reference material (CRM) so you know that it meets strict ISO quality requirements.

From potency to pesticides analysis, Restek offers the LC and GC chromatography columns, CRMs, accessories, and sample prep supplies, as well as technical literature and support, needed for accurate, reliable medical marijuana analysis. Learn more about Restek’s products and resources at www.restek.com/medical-cannabis and start growing your medical cannabis testing business today.

Latest News

Lab Asia 33.4 - August 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
EU adopts sum-based PFAS and bisphenol limits for surface water and groundwater
Explore more Arrow
Pollution Solutions Online
Safe drinking water worldwide
Explore more Arrow
Petro Online
EU delays methane import penalties but leaves MRV obligations in place from 2027
Explore more Arrow
Chromatography Today
Inline degasser range upgraded with new vacuum control and pump technology
Explore more Arrow